Case number: 4:25-bk-30395 - Vyripharm Biopharmaceuticals, Inc. - Texas Southern Bankruptcy Court

Case Information
  • Case title

    Vyripharm Biopharmaceuticals, Inc.

  • Court

    Texas Southern (txsbke)

  • Chapter

    11

  • Judge

    Jeffrey P Norman

  • Filed

    01/27/2025

  • Last Filing

    06/13/2025

  • Asset

    Yes

  • Vol

    v

Docket Header
PlnDue, DsclsDue



U.S. Bankruptcy Court
Southern District of Texas (Houston)
Bankruptcy Petition #: 25-30395

Assigned to: Bankruptcy Judge Jeffrey P Norman
Chapter 11
Voluntary
Asset


Date filed:  01/27/2025
341 meeting:  03/03/2025
Deadline for filing claims:  04/07/2025
Deadline for filing claims (govt.):  07/28/2025

Debtor

Vyripharm Biopharmaceuticals, Inc.

7205 Almeda Road, Suite 300591
Houston, TX 77054
HARRIS-TX
Tax ID / EIN: 85-4177026

represented by
Susan Tran Adams

Tran Singh LLP
2502 La Branch Street
Houston, TX 77004
832-975-7300
Fax : 832-975-7301
Email: stran@ts-llp.com

Trustee

Melissa A Haselden

Haselden Farrow PLLC
Pennzoil Place
700 Milam
Suite 1300
Houston, TX 77002
832.819.1149

 
 
U.S. Trustee

US Trustee

Office of the US Trustee
515 Rusk Ave
Ste 3516
Houston, TX 77002
713-718-4650
represented by
Hector Duran, Jr

U.S. Trustee
515 Rusk
Ste 3516
Houston, Tx 77002
7137184650
Email: Hector.Duran.Jr@usdoj.gov

Latest Dockets

Date Filed#Docket Text
06/13/202535Chapter 11 Small Business Subchapter V Plan Filed by Vyripharm Biopharmaceuticals, Inc.. (Attachments: # (1) Redline Amended Plan) (Adams, Susan)
05/30/202534BNC Certificate of Mailing. (Related document(s):[33] Order Setting Hearing) No. of Notices: 2. Notice Date 05/30/2025. (Admin.)
05/28/202533Status Conference Order Signed on 5/28/2025. ORDERS the Debtor to file and serve an Amended Chapter 11 Plan not later than June 13, 2025. Confirmation hearing to be held on 7/21/2025 at 09:30 AM at Houston, Courtroom 403 (JPN). (trc4)
05/28/202532Courtroom Minutes. Time Hearing Held: 10:30. Appearances: Susan Tran for the debtor, U.S. Trustee Hector Duran, Subchapter V Trustee Melissa Haselden, Sam Daffin Representative Jerry Bryant President. (Related document(s):[1] Voluntary Petition (Chapter 11)) Status Conference held. Parties agreed to 60 days for an amended plan to be filed. Court will enter order scheduling Confirmation 07/21/2025 at 9:30 AM, 403 Courtroom. (srh4)
05/23/202531Debtor-In-Possession Monthly Operating Report for Filing Period ending 4/30/2025, $0 disbursed (Filed By Vyripharm Biopharmaceuticals, Inc. ). (Adams, Susan)
05/22/202530BNC Certificate of Mailing. (Related document(s):[29] Generic Order) No. of Notices: 2. Notice Date 05/22/2025. (Admin.)
05/20/202529Order Converting Hearing to Status Conference Signed on 5/20/2025 (Related document(s):[23] Chapter 11 Small Business Subchapter V Plan ) Status Conference scheduled 05/28/2025 at 10:30 AM, Courtroom 403, Houston, Texas. (srh4)
05/19/202528Motion to Continue Hearing On (related document(s):[23] Chapter 11 Small Business Subchapter V Plan, [24] Order Setting Hearing). Filed by Debtor Vyripharm Biopharmaceuticals, Inc. (Attachments: # (1) Proposed Order # (2) Service List) (Adams, Susan)
05/08/202527Withdrawal of Claim: 2 (Brown, Silvia)
04/30/202526BNC Certificate of Mailing. (Related document(s):[24] Order Setting Hearing) No. of Notices: 2. Notice Date 04/30/2025. (Admin.)